Kasowitz LLP is recognized for its trial-ready approach to complex commercial disputes, securities litigation, and antitrust defense. The firm regularly
represents Fortune 500 companies, financial institutions, and high-profile clients in bet-the-company cases.
One client describes the team as “extraordinarily detailed, professional and communicative with me as the client” while another client praised their “communication and competence” as well as their “breadth and depth of experience.”
Name partner and founder
Marc Kasowitz,
along with new litigation star
Edward Filusch,
represent
Gilimex, a Vietnamese manufacturer, in a lawsuit against Amazon Robotics for allegedly inducing it to expand production based on false forecasts, then cutting ties which allegedly devastated its business. Courts in New York have twice denied Amazon’s attempts to dismiss or win summary judgment, finding
Gilimex
plausibly alleged fiduciary duty, misrepresentation, and unfair trade practices. The case, seeking over $100 million in damages, is now headed to trial. Marc Kasowitz also paired with
Ronald Rossi to
represent Calverton Aviation & Technology in a lawsuit against the Town of Riverhead and its agencies over a failed $40 million deal to purchase and develop
1,643 acres at the Enterprise Park at Calverton. The client alleges the town schemed to avoid its contractual obligations by improperly influencing officials to declare it unqualified, despite its ability to pay in cash. The client seeks specific performance of the contract, damages, and an order compelling Riverhead to complete the sale.
Daniel Saunders was co-lead counsel to the Witkoff Group and its affiliates in a high-profile lawsuit brought by a former CEO of a planned resort and casino who sued after the project ceased development alleging the Witkoff Group and its affiliates continued to owe him substantial compensation even though the project was terminated. The matter was successfully resolved months before trial.
Kenneth David defended JBS and Pilgrim’s Pride in a DOJ criminal antitrust probe, securing a favorable plea deal limiting charges to a single Sherman Act violation and a $107 million fine. The firm also resolved multidistrict
grower litigation with a $100 million settlement, avoiding any admission of liability.
Sharon
Korpus continues to shine as a member of the lead counsel team representing Teva and its individual directors and officers in defense of one of the largest securities class actions in the last few years, as well as the more than 20 related direct actions, filed on behalf of more than 75 opt-out plaintiffs. The Kasowitz team continues its active representation of the pharmaceutical giant in antitrust and white-collar litigation. Fellow securities litigator
Stephen Tountas filed five direct securities fraud suits against Valeant Pharmaceuticals on behalf of major investors, including Mississippi PERS, Catalyst Mutual Funds, Northwestern Mutual, Privet Capital, and Boeing retirement plans. The claims alleged Valeant misled shareholders about its business model, improperly accounted for sales through hidden subsidiaries, and had defective internal controls. Mississippi PERS’ case was the first to assert liability under both federal securities laws and the New Jersey RICO Act, surviving dismissal. After defeating summary judgment, the team secured favorable settlements across all actions by 2025.
